This study is led by Professor Junnian Zheng and Ming Shi from the Cancer Institute of Xuzhou Medical University, together with the team of Professor Guiyun Cui and Wei Zhang from the Affiliated Hospital of Xuzhou Medical University.
Innovative CAR T cell therapy shows promise for relapsed CIDP patients
- Post author:
- Post published:June 21, 2024
- Post category:uncategorized